top of page

Divergent Patent Law Blog

Commentary on U.S patent prosecution, PTAB practice, Federal Circuit developments, and cross-border patent strategy.

From Festo to File History: Comparing U.S. Prosecution History Estoppel with EPO, Korean, Japanese, and Chinese Constraints on Claim Scope

  • Writer: Brandon Theiss
    Brandon Theiss
  • 5 days ago
  • 22 min read

Executive Summary: This article compares how prosecution history can limit patent claim scope in the United States, the EPO, Korea, Japan, and China. In the United States, prosecution history operates through several related doctrines: ordinary claim construction, prosecution disclaimer, amendment-based prosecution history estoppel under Festo, and argument-based estoppel where applicant remarks clearly surrender subject matter. The EPO stands apart because EPC proceedings generally do not recognize U.S.-style file-wrapper estoppel, although the description, drawings, and amendment rules remain central to claim interpretation and validity. Korea and Japan recognize functional analogues through doctrine-of-equivalents limitations: Korea asks whether the prosecution record as a whole shows conscious exclusion, while Japan applies the fifth Ball Spline “special circumstances” requirement, refined by Maxacalcitol to require objective conduct indicating exclusion. China more directly precludes recapture of surrendered technical solutions where the patentee gave them up through amendment or observation during grant or invalidation, subject to an important qualification where the narrowing position was specifically denied; China’s separate donation principle also limits disclosed-but-unclaimed subject matter. The practical lesson for global patent prosecution is that amendments and arguments should be drafted as future litigation evidence: distinguish the art precisely, avoid unnecessary invention-level admissions, preserve commercially important alternatives in claims, and coordinate prosecution positions across jurisdictions.


I.             Introduction


Patent prosecutors write for many audiences at once. An amendment or office-action response must persuade an examiner, preserve validity, avoid added matter, maintain commercial claim scope, and anticipate future infringement litigation. That tension is especially acute in coordinated global prosecution. A statement made to overcome prior art in one jurisdiction may later be read by a court, tribunal, opposition division, invalidity petitioner, or competitor as a limitation on claim scope.


The United States supplies the most familiar terminology: prosecution history estoppel. But the U.S. doctrine is only one way in which prosecution conduct can constrain a patentee. U.S. courts also use prosecution history in ordinary claim construction and may apply prosecution disclaimer when the applicant clearly and unmistakably surrenders a claim meaning. Accordingly, in the U.S. “anything you say, can and will be used against you in a court of patent law.”

The European Patent Office, by contrast, generally does not recognize “file wrapper estoppel” in EPC proceedings. Korea, Japan, and China recognize closer functional analogues, but those analogues are framed differently: Korea through intentional or conscious exclusion, Japan through the fifth “special circumstances” requirement for equivalents, and China through the surrender of technical solutions in patent granting or confirmation proceedings.


The comparative lesson is not that every jurisdiction has a U.S.-style Festo rule. They do not. The lesson is more practical: prosecution history is often long-lived evidence of claim meaning, claim-scope compromise, or subject-matter surrender. The legal effect varies sharply by jurisdiction, but the record rarely disappears.

 

II.          United States: Prosecution History as Claim-Construction Evidence, Disclaimer, and Estoppel


A. Three different ways the U.S. prosecution record can matter


U.S. law uses the prosecution record in at least three analytically distinct ways.

First, prosecution history is intrinsic evidence for ordinary claim construction. In Phillips v. AWH Corp., the Federal Circuit explained that the prosecution history includes the complete record before the Patent and Trademark Office, including the prior art cited during examination, and may show how the inventor and the PTO understood the invention. Phillips v. AWH Corp., 415 F.3d 1303, 1317 (Fed. Cir. 2005) (en banc). The court also cautioned that prosecution history is often less clear than the specification because it reflects an ongoing negotiation between applicant and examiner rather than a final, self-contained technical description. Id. 


Second, prosecution history may create prosecution disclaimer, sometimes called prosecution disavowal. This is a claim-construction doctrine. If the applicant makes a clear and unmistakable representation to obtain allowance, the court may construe the claim to exclude the surrendered meaning. The Federal Circuit’s formulation in Omega Engineering remains a useful baseline: prosecution disclaimer promotes public notice and prevents patentees from recapturing through claim interpretation meanings that they clearly disclaimed during prosecution, but ambiguous statements do not suffice. Omega Eng’g, Inc. v. Raytek Corp., 334 F.3d 1314, 1323–26 (Fed. Cir. 2003).


Third, prosecution history may create prosecution history estoppel, which is primarily a limitation on the doctrine of equivalents. Under Festo, a narrowing amendment made for a reason related to patentability can presumptively surrender the territory between the original and amended claim, subject to recognized rebuttal routes. Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., 535 U.S. 722, 733–41 (2002).


These doctrines overlap in the evidence they examine, but they should not be collapsed. A prosecution statement may inform the ordinary meaning of a claim without creating disclaimer. A disclaimer may narrow literal claim scope without invoking the doctrine of equivalents. And Festo estoppel may bar equivalents even where literal claim construction is otherwise unaffected.

B. Claim interpretation in

light of examiner-cited prior art


Because the prosecution history includes the prior art cited during examination, examiner-cited art is part of the interpretive record. But cited art does not automatically narrow the claims. The relevant question is not simply, “What did the cited reference disclose?” The better question is, “How did the examiner apply the reference, and what did the applicant say or amend in response?”


That distinction matters. An examiner may cite a reference in an anticipation rejection, combine it with other references in an obviousness rejection, list it on a notice of references cited, discuss it in reasons for allowance, or merely consider it through an information disclosure statement. Each circumstance carries different interpretive weight. A reference applied in a rejection and distinguished by the applicant is typically more probative than a reference merely listed among many cited documents. Even then, the reference informs claim meaning only through its relationship to the claim language, rejection theory, amendment, and response.


A useful rule for courts and prosecutors is this: examiner-cited art is context, not a negative limitation. The claims should not be interpreted to exclude everything shown in a cited reference merely because the reference was before the examiner. They should be interpreted in light of the cited art only to the extent the applicant or the examiner’s accepted reasoning tied that art to the meaning of a disputed claim term.

Applicant responses usually matter more than the mere citation of the art. A response saying “Reference A does not disclose the recited fastener” is narrower and safer than a response saying “the invention excludes clips.” The former may be a factual distinction about a particular claim element; the latter may be read as a claim-scope surrender. Similarly, an argument that two references cannot be combined may have little claim-construction significance unless the argument depends on a representation about what the claim requires or excludes.


The Federal Circuit’s 2025 decision in Eye Therapies v. Slayback illustrates how examiner-cited art, amendment, applicant remarks, and reasons for allowance can interact. There, the applicant amended claim language from “comprising” to “consisting essentially of” after a rejection over Dean and argued that Dean involved brimonidine with another active ingredient. The examiner’s reasons for allowance echoed the applicant’s position. The Federal Circuit construed the phrase “consisting essentially of” more restrictively than its ordinary transitional effect, holding that the prosecution record limited the claims to compositions excluding additional active ingredients. Eye Therapies, LLC v. Slayback Pharma LLC, No. 23-2173, slip op. at 7–12 (Fed. Cir. June 30, 2025).


The important point is not that every amendment from “comprising” to “consisting essentially of” has the same effect. The important point is that the court read the claim term through the whole prosecution sequence: the Dean rejection, the applicant’s amendment, the applicant’s explanation, and the examiner’s allowance rationale. In that setting, the art cited by the examiner did not operate alone; it mattered because the applicant used the art to define the patentable distinction.


C. Examiner’s reasons for allowance


Examiner’s reasons for allowance occupy a special position in U.S. claim construction. They are part of the file history and can illuminate what the examiner believed distinguished the claims from the prior art. But they are usually not, standing alone, an applicant surrender.

The regulation governing reasons for allowance provides that, when the record does not make the reasons for allowance clear, the examiner may set forth those reasons. It also permits the applicant or patent owner to file a statement commenting on the reasons for allowance and states that the examiner’s failure to respond to such a statement does not give rise to an implication. 37 C.F.R. § 1.104(e).


The MPEP is even more explicit about the limited estoppel effect of unilateral examiner commentary. It describes reasons for allowance as an important part of the file history, but also characterizes them as the examiner’s personal opinion and states that the examiner’s statement should not create estoppel; only applicant statements should do so. MPEP § 1302.14.


The leading Federal Circuit case is Salazar v. Procter & Gamble Co., 414 F.3d 1342 (Fed. Cir. 2005). There, the court rejected the argument that a unilateral examiner statement in reasons for allowance created a clear and unmistakable disavowal or prosecution history estoppel. The applicant’s silence did not amount to adoption of the examiner’s characterization. At the same time, Salazar did not hold that examiner statements are irrelevant. The court recognized that examiner statements may be evidence of how a person of skill in the art understood the claim at the time. Id. at 1345–47.


A recent contrast is Maquet Cardiovascular LLC v. Abiomed Inc., No. 23-2045, slip op. at 17–19 (Fed. Cir. Mar. 21, 2025). There, the Federal Circuit considered prosecution history from a related patent and examiner commentary regarding the Völker reference. The court treated related prosecution history as potentially relevant when it addressed sufficiently common claim language, but it rejected clear disavowal based on applicant silence in response to the notice of allowance.


The practical synthesis is straightforward. Examiner’s reasons for allowance are strongest when they repeat, adopt, or confirm the applicant’s own narrowing argument. They are weakest when they are unilateral, unexplained, or not tied to the disputed claim language. Silence in response to reasons for allowance ordinarily should not be treated as affirmative adoption. By contrast, an applicant’s comment on the reasons for allowance may itself become a claim-scope statement.


D. Prosecution disclaimer: clear surrender in the applicant’s own words


Prosecution disclaimer is often where the cited art and applicant response do the most work. Courts look for clear and unmistakable surrender. That standard is demanding because patents are public notice instruments: competitors are entitled to rely on what the applicant clearly gave up, but they are not entitled to manufacture surrender from ambiguous advocacy.


An applicant may create disclaimer by amending claims and explaining that the amendment distinguishes prior art for a particular reason. The applicant may also create disclaimer without amendment by making a clear argument about what the claims require or do not cover. For example, if an applicant distinguishes prior art on the ground that the claimed “fastener” must be threaded and the prior art uses an unthreaded clip, a later court may construe “fastener” to require threading if the statement was clear, repeated, and necessary to allowance. If the applicant merely argues that the prior art’s clip is not the recited “fastener” in the specific context of the reference, the effect may be narrower.


The scope of disclaimer should be congruent with the surrender. Omega Eng’g, 334 F.3d at 1325–26. A disclaimer based on distinguishing a spring-loaded clip should not automatically exclude all non-screw fasteners unless the applicant’s statement actually reached that far.


E. Prosecution history estoppel after Festo


Once claim construction is complete, a patentee may still seek infringement under the doctrine of equivalents. That is where Festo prosecution history estoppel operates most directly.


In Festo, the Supreme Court held that a narrowing amendment made to satisfy any requirement of the Patent Act may give rise to estoppel if the amendment narrows the claim for a patentability-related reason. The Court rejected a complete bar, but it adopted a presumption that the patentee surrendered all equivalents within the territory between the broader original claim and the narrower amended claim. Festo, 535 U.S. at 736–41.

The patentee may rebut that presumption by showing that the alleged equivalent was unforeseeable at the time of amendment, that the rationale underlying the amendment bore only a tangential relation to the equivalent, or that there was some other reason the patentee could not reasonably have been expected to describe the equivalent. Id. at 740–41.

The Festo framework is more formal than prosecution disclaimer. Disclaimer asks whether the applicant clearly narrowed literal claim meaning. Festo asks whether a narrowing amendment presumptively surrendered territory for equivalents purposes. The same prosecution event may matter under both doctrines, but the doctrinal paths and consequences differ.


F. Argument-Based Estoppel and the Doctrine of Equivalents


U.S. prosecution history estoppel is not limited to narrowing amendments. Even without an amendment that triggers the Festo presumption, an applicant may surrender subject matter through arguments made to the examiner, and that surrender may bar later reliance on the doctrine of equivalents. The Federal Circuit has described prosecution history estoppel as arising either “by making a narrowing amendment to the claim” or “by surrendering claim scope through argument to the patent examiner.” Conoco, Inc. v. Energy & Env’t Int’l, L.C., 460 F.3d 1349, 1363 (Fed. Cir. 2006); see also Amgen Inc. v. Coherus BioSciences Inc., 931 F.3d 1154, 1159–60 (Fed. Cir. 2019).


The standard for argument-based estoppel is demanding. The prosecution history must show a “clear and unmistakable surrender” of the relevant subject matter, and the question is whether a competitor would reasonably understand that the applicant had given up the asserted equivalent. Deering Precision Instruments, LLC v. Vector Distribution Sys., Inc., 347 F.3d 1314, 1326 (Fed. Cir. 2003); PODS, Inc. v. Porta Stor, Inc., 484 F.3d 1359, 1367–68 (Fed. Cir. 2007); Amgen, 931 F.3d at 1159–60.


Amgen v. Coherus is a useful modern illustration. Amgen asserted infringement under the doctrine of equivalents because the accused process used a salt combination that was not one of the salt combinations recited in the claims. During prosecution, however, Amgen had distinguished the Holtz prior art by emphasizing the “particular combinations of salts” recited in the claims. The Federal Circuit held that Amgen had clearly and unmistakably surrendered unclaimed salt combinations and therefore could not recapture them through equivalents. Amgen, 931 F.3d at 1159–61.


Argument-based estoppel also matters where an applicant gives multiple independent reasons for patentability. If the applicant distinguishes prior art on several separate grounds, each ground can create a separate estoppel, so long as the applicant did not rely only on the combination of those grounds. PODS, 484 F.3d at 1367; Southwall Techs., Inc. v. Cardinal IG Co., 54 F.3d 1570, 1581–83 (Fed. Cir. 1995). Nor must the argument appear in the final response before allowance; an earlier clear surrender is not erased merely because the applicant later obtains allowance on a different or narrower presentation. Amgen, 931 F.3d at 1160–61.

 

III.      The EPO: Claim Interpretation Without U.S.-Style File Wrapper Estoppel


The EPO comparison begins with an institutional distinction. The EPO examines applications, grants European patents, and adjudicates oppositions and appeals under the EPC; infringement is generally handled outside the EPO, by national courts or the Unified Patent Court. For that reason, the proper comparison is not whether EPO boards apply U.S. prosecution history estoppel in infringement litigation, but whether EPC proceedings recognize a binding file-wrapper-estoppel principle.

They generally do not.


Article 69 EPC and its Protocol frame the extent of protection by reference to the claims, interpreted using the description and drawings. The Protocol rejects both a strictly literal approach and an approach that treats claims as mere guidelines, requiring a balance between fair protection for the patentee and reasonable legal certainty for third parties. It also provides that equivalents should be taken into account when determining the extent of protection. Protocol on the Interpretation of Article 69 EPC arts. 1–2.

In 2025, the Enlarged Board in G 1/24 addressed claim interpretation for patentability under the EPC. The Enlarged Board held that the claims are the starting point and basis for assessing patentability and that the description and drawings are to be consulted when interpreting claims, not only when claim language is ambiguous. G 1/24, ECLI:EP:BA:2025:G000124.20250618 (Enlarged Bd. App. June 18, 2025).


That is claim interpretation, not estoppel. The clearest recent EPO statement on file-wrapper estoppel appears in T 0325/23. The Technical Board of Appeal stated that, in general, there is no file-wrapper estoppel under the EPC; the concept is a U.S. doctrine and does not exist as such in EPC proceedings. The Board accepted that prosecution-history events may indicate that a narrow interpretation is technically reasonable, but rejected the idea that those events bind all later EPC proceedings or exclude other technically reasonable interpretations. T 0325/23, ECLI:EP:BA:2024:T032523.20241210 (Tech. Bd. App. Dec. 10, 2024).


The closest EPO analogues are therefore not estoppel doctrines in the U.S. sense. They are doctrines that police the permissible content and effect of amendments: added matter under Article 123(2) EPC, impermissible extension of protection after grant under Article 123(3) EPC, strict treatment of undisclosed disclaimers, intermediate generalization, clarity objections in examination, and claim interpretation using the description and drawings. Those mechanisms can be severe, but they are not the same as a litigation rule barring recapture of surrendered subject matter through equivalents.

For prosecution strategy, the EPO lesson differs from the U.S. lesson. Before the EPO, the greater immediate risk is often creating amendment-basis, added-matter, or clarity problems. But EPO statements should still be drafted with litigation in mind, because national courts and the UPC may consider prosecution records differently from the EPO Boards of Appeal.


IV.  Korea: Conscious Exclusion, Not Mechanical Surrender


Korea recognizes a functional analogue to prosecution history estoppel, but Korean doctrine is more contextual than a U.S.-style Festo presumption. In claim construction, Korean law starts with the claim language. The claims define the protected invention, and the specification, drawings, common general knowledge, and prosecution history may be used to understand the technical meaning of the claim language. But Korean guidance cautions that prosecution-history materials should not be used to broaden or narrow the wording of the claims beyond what the claim language can reasonably bear. See Patent System of the Republic of Korea, WIPO Patent Judicial Guide § 8.5.1.2.


The closer analogue to prosecution history estoppel appears in Korea’s doctrine of equivalents. Korean equivalents analysis includes positive requirements—identity of solution principle, substantial identity of effect, and ease of replacement—and negative requirements, including that the accused or compared technology must not be free-to-practice public-domain technology and that the replaced element must not have been purposefully excluded from the scope of the claims during prosecution. The patentee bears the burden on the positive requirements, while the alleged infringer bears the burden on the negative requirements. See id. § 8.5.2.3.


The important refinement is that Korean law does not treat every narrowing amendment as an automatic surrender of the full territory between the original and amended claim. In Daebeobwon [Supreme Court], Feb. 2, 2023, 2022Hu10210 (S. Kor.), the Korean Supreme Court held that whether a configuration was consciously excluded from the claims must be assessed by considering not only the specification, but also the examiner’s views during prosecution, the applicant’s amendments and written arguments, the applicant’s intent, and the reasons for amendment. The Court expressly rejected a mechanical comparison between the pre-amendment and post-amendment claim language as sufficient to conclude that all intervening configurations were consciously excluded.


The facts of 2022Hu10210 illustrate the point. The applicant had deleted “prodrug ester” language during prosecution, but the Supreme Court held that the accused dapagliflozin formate had not been consciously excluded from the claim scope. The Court affirmed the lower court’s conclusion that the accused subject matter remained within the equivalent scope of the asserted claims and rejected the argument that the deletion, by itself, created prosecution-history estoppel. Daebeobwon [Supreme Court], Feb. 2, 2023, 2022Hu10210 (S. Kor.).


The Korean approach is therefore closer to an intent- or record-based “conscious exclusion” inquiry than to a bright-line amendment-surrender rule. Conscious exclusion may be found where, for example, the applicant narrowed the claim to avoid prior art cited in a rejection and the overall record shows an intention to exclude the prior-art configuration. But the inference must come from the prosecution record as a whole, including the reasons for amendment. A narrowing amendment is powerful evidence, but it is not conclusive evidence.

For prosecution practice, Korean responses should make the purpose of amendments clear. If an amendment is made to address a specific rejection, the record should identify that limited purpose. Prosecutors should avoid unnecessary statements suggesting that unclaimed variants are outside the invention as such, particularly where those variants may later be important equivalents.


V.       Japan: The Fifth Ball Spline Requirement and Objective Exclusion


Japan also recognizes a functional analogue to prosecution history estoppel, but it is embedded in the doctrine of equivalents rather than framed as a separate U.S.-style estoppel doctrine. Japanese Patent Act Article 70 provides that the technical scope of a patented invention is determined based on the claims, with claim terms interpreted in light of the specification and drawings. Tokkyo Hō [Patent Act], Law No. 121 of 1959, art. 70 (Japan).

The Japanese Supreme Court recognized the doctrine of equivalents in the Ball Spline Bearing case. Saikō Saibansho [Sup. Ct.] Feb. 24, 1998, Hei 6 (O) No. 1083, 52(1) Minshū 114 (Japan). The five requirements are: the differing element is not an essential part of the invention; replacement achieves the object of the invention and produces the same effect; the replacement would have been easily conceived by a skilled person at the time of manufacture or infringement; the accused product was not identical to, or easily conceived from, public-domain technology at filing; and there are no special circumstances, such as exclusion of the accused product from the claims during prosecution.


The fifth requirement is the key comparator. It asks whether “special circumstances” preclude equivalents, including circumstances in which the applicant intentionally excluded the accused product or process from the claim scope during prosecution. In this respect, Japan resembles prosecution history estoppel, but the structure is different. The Japanese inquiry is not triggered by a U.S.-style presumption that every narrowing amendment made for patentability reasons surrenders the entire intermediate territory. Rather, the inquiry asks whether the patentee’s conduct objectively supports treating the accused variant as excluded.


The modern refinement comes from Maxacalcitol. Saikō Saibansho [Sup. Ct.] Mar. 24, 2017, Hei 28 (Ju) No. 1242, 71(3) Minshū 359 (Japan). The Supreme Court held that the mere fact that the applicant failed to claim a foreseeable alternative does not, by itself, establish special circumstances barring equivalents. The Court explained that special circumstances may exist where it is objectively and visibly clear that the applicant omitted the alternative from the claims while recognizing that it could substitute for the claimed structure.

That distinction is critical. In Maxacalcitol, the accused process used a trans-form vitamin D structure rather than the claimed cis-form structure. The accused infringers argued that the patentee could have claimed the trans-form structure and therefore should be barred from asserting equivalents. The Supreme Court rejected that argument because the record did not objectively and externally show that the applicant recognized the trans-form structure as a substitute and deliberately omitted it from the claims. Maxacalcitol, Hei 28 (Ju) No. 1242.

Japan therefore has a meaningful but limited analogue to prosecution history estoppel. The fifth Ball Spline requirement can bar equivalents where the applicant’s conduct objectively indicates exclusion. But mere foreseeability, standing alone, is insufficient. This makes Japan closer to Korea’s record-sensitive conscious-exclusion inquiry than to the U.S. Festo presumption.


For prosecution practice, Japanese responses should avoid statements that make an unclaimed alternative look like a known substitute that the applicant deliberately chose not to claim. If a narrowing amendment is made only to distinguish a cited reference or clarify language, the response should say so. The specification and dependent claims should preserve commercially important alternatives where possible.


VI.  China: Surrendered Technical Solutions, Good Faith, and the Adjacent Donation Principle


China’s analogue is more direct than the Korean and Japanese versions because Chinese judicial doctrine expressly precludes recapture of surrendered technical solutions in infringement litigation. The rule is grounded in consistency, good faith, and the public-notice function of the prosecution and invalidation record.

Chinese infringement analysis recognizes equivalents, but the doctrine is subject to several limiting principles. The Supreme People’s Court has described the estoppel rule as a limitation on equivalents designed to require parties to act in good faith and to prevent patentees from interpreting claims in infringement litigation inconsistently with positions taken in patent granting and confirmation procedures. See Patent System of China, WIPO Patent Judicial Guide § 4.3.2.5.

The core rule appears in Article 6 of the Supreme People’s Court’s 2009 patent-infringement interpretation. It provides that, where the patentee or applicant abandoned a technical solution through amendment of the claims or specification, or through a statement during patent granting or invalidation, the court will not support the patentee’s attempt to include that technical solution within the patent’s protection scope in infringement litigation. Zuigao Renmin Fayuan Guanyu Shenli Qinfan Zhuanliquan Jiufen Anjian Yingyong Falü Ruogan Wenti de Jieshi [Interpretation of the Supreme People’s Court on Several Issues Concerning the Application of Law in the Trial of Patent Infringement Dispute Cases] art. 6 (promulgated Dec. 28, 2009, effective Jan. 1, 2010) (China).


This makes China closer to the U.S. than the EPO is. A prosecution or invalidation statement can later operate as a preclusion rule in infringement litigation. But the Chinese terminology is different. The question is not whether a Festo presumption applies; it is whether a particular “technical solution” was surrendered through observations or amendments in grant or invalidation proceedings. The focus is on the surrendered solution, the administrative record, and the patentee’s later attempt to recapture the solution.

The later interpretive qualification is important. Article 13 of the Supreme People’s Court’s second patent-infringement interpretation provides that, where the right holder proves that a narrowing amendment or statement concerning the claims, specification, or drawings was specifically denied in patent granting or confirmation proceedings, the court should find that the amendment or statement did not surrender the technical solution. Zuigao Renmin Fayuan Guanyu Shenli Qinfan Zhuanliquan Jiufen Anjian Yingyong Falü Ruogan Wenti de Jieshi (Er) [Interpretation (II) of the Supreme People’s Court on Several Issues Concerning the Application of Law in the Trial of Patent Infringement Dispute Cases] art. 13 (promulgated Jan. 25, 2016, amended Dec. 23, 2020) (China).


That qualification prevents over-reading the prosecution record. If the applicant made a narrowing statement but the patent office or later reviewing body did not accept that statement as a basis for grant or maintenance, the rationale for estoppel is weaker. Chinese guidance also indicates that, in assessing whether a narrowing statement was “specifically denied,” courts consider whether the decision-maker ultimately accepted the statement and whether the patent was granted or maintained valid on that basis.


China also has an adjacent but distinct donation principle. Article 5 of the 2009 Supreme People’s Court interpretation provides that, where a technical solution is described only in the specification or drawings but not recited in the claims, the court will not support the patentee’s attempt to include that solution within the patent’s protection scope in infringement litigation. This is analytically different from prosecution-history surrender. Estoppel concerns what the patentee gave up through amendment or argument; donation concerns what the patentee disclosed but did not claim. Both doctrines limit later expansion through equivalents, but they operate on different records and different theories. Interpretation of the Supreme People’s Court on Several Issues Concerning the Application of Law in the Trial of Patent Infringement Dispute Cases arts. 5–6.


For prosecution and invalidation practice, China calls for particular care in both original examination and post-grant proceedings. Statements made to obtain grant, preserve validity, or distinguish a reference may later define a surrendered technical solution. At the same time, commercially important alternatives should not merely be disclosed in the specification; where possible, they should be claimed, because disclosed-but-unclaimed solutions may be treated as donated to the public.

 

VII.   Comparative Synthesis


The jurisdictions can be grouped into three broad categories.

The first category is the United States. U.S. law has a formal prosecution-history-estoppel doctrine, a separate prosecution-disclaimer doctrine, and a robust tradition of using prosecution history as intrinsic evidence in claim construction. The prosecution record matters both before and after the doctrine of equivalents enters the analysis.

The second category is the EPO. The EPO uses the description and drawings in claim interpretation and strictly polices amendments under the EPC, but it does not recognize U.S.-style file-wrapper estoppel in EPC proceedings. Prosecution history may provide technical context, but it does not operate as a binding surrender doctrine under the EPC.

The third category includes Korea, Japan, and China. These jurisdictions recognize functional analogues to estoppel, but not as copies of U.S. Festo. Korea and Japan ask whether the applicant intentionally or objectively excluded the accused configuration. China asks whether the patentee surrendered a technical solution through amendment or statement in granting or confirmation proceedings.

Issue

United States

EPO

Korea

Japan

China

Closest doctrine

Prosecution history estoppel; prosecution disclaimer

No true file-wrapper estoppel in EPC proceedings

Conscious or purposeful exclusion

Fifth Ball Spline “special circumstances” requirement

Surrendered technical solution; adjacent donation principle

Main legal setting

Claim construction and doctrine of equivalents in infringement litigation

Examination, opposition, limitation, appeal; infringement handled outside EPO

Doctrine of equivalents and scope-related proceedings

Doctrine of equivalents in infringement litigation

Infringement litigation informed by grant and invalidation records

Trigger

Narrowing amendment or clear applicant surrender

No binding estoppel trigger under EPC practice

Whole prosecution record shows intent to exclude

Objective and visible conduct showing intentional exclusion

Amendment or observation surrendering a technical solution

Mechanical effect?

Festo presumption after qualifying narrowing amendment

No

No; narrowing amendment alone is insufficient

No; mere failure to claim foreseeable alternative is insufficient

More direct, but no surrender if narrowing position was specifically denied

Adjacent doctrine

Disclosure-dedication doctrine

Added matter; Article 123(3); claim interpretation under Article 69

Public-domain/free-to-practice limitation

Public-domain limitation and special circumstances

Donation principle for disclosed-but-unclaimed technical solutions

 

 

VIII.                  Conclusion


Prosecution history is not a uniform global doctrine, and the non-U.S. systems should not be described as simple variations on Festo. The United States remains the clearest example of a formal prosecution-history-estoppel regime: a narrowing amendment made for a patentability-related reason can presumptively bar the patentee from recapturing surrendered territory through the doctrine of equivalents. Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., 535 U.S. 722, 736–41 (2002). U.S. law also gives prosecution history an important role in ordinary claim construction and prosecution disclaimer, particularly where applicant amendments and remarks clearly distinguish examiner-cited art. Phillips v. AWH Corp., 415 F.3d 1303, 1317 (Fed. Cir. 2005) (en banc); Omega Eng’g, Inc. v. Raytek Corp., 334 F.3d 1314, 1323–26 (Fed. Cir. 2003). Examiner’s reasons for allowance may inform claim meaning, especially when they echo the applicant’s own narrowing arguments, but unilateral examiner statements and applicant silence ordinarily should not create surrender. Salazar v. Procter & Gamble Co., 414 F.3d 1342, 1345–47 (Fed. Cir. 2005).

The EPO stands apart. Although the EPC requires claims to be interpreted in light of the description and drawings, and although EPO practice strictly polices amendment issues such as added matter and extension of protection, EPO proceedings do not recognize U.S.-style file-wrapper estoppel. The prosecution record may provide technical context, but it does not operate as a binding estoppel doctrine under the EPC. See Protocol on the Interpretation of Article 69 EPC arts. 1–2; T 0325/23, ECLI:EP:BA:2024:T032523.20241210 (Tech. Bd. App. Dec. 10, 2024).

Korea, Japan, and China provide closer functional analogues, but each uses its own doctrinal structure. Korea’s doctrine of conscious or purposeful exclusion requires a comprehensive review of the prosecution record and rejects automatic surrender based solely on narrowing amendments. The question is not whether the applicant narrowed the claim in the abstract, but whether the record as a whole—including examiner views, amendments, applicant arguments, reasons for amendment, and applicant intent—shows that the specific accused configuration was consciously excluded. Daebeobwon [Supreme Court], Feb. 2, 2023, 2022Hu10210 (S. Kor.).


Japan likewise treats the issue through the doctrine of equivalents, specifically the fifth Ball Spline requirement that there be no “special circumstances” precluding equivalence. Saikō Saibansho [Sup. Ct.] Feb. 24, 1998, Hei 6 (O) No. 1083, 52(1) Minshū 114 (Japan). The Supreme Court’s Maxacalcitol decision confirms that mere failure to claim a foreseeable alternative is not enough; the patentee’s conduct must objectively and externally indicate that the alternative was recognized as a substitute and deliberately left outside the claims. Saikō Saibansho [Sup. Ct.] Mar. 24, 2017, Hei 28 (Ju) No. 1242, 71(3) Minshū 359 (Japan).

China’s doctrine is more directly preclusive. Where a patentee or applicant surrenders a technical solution through amendments or observations during grant or invalidation, Chinese courts generally will not permit the patentee to recapture that solution in infringement litigation. Zuigao Renmin Fayuan Guanyu Shenli Qinfan Zhuanliquan Jiufen Anjian Yingyong Falü Ruogan Wenti de Jieshi [Interpretation of the Supreme People’s Court on Several Issues Concerning the Application of Law in the Trial of Patent Infringement Dispute Cases] art. 6 (promulgated Dec. 28, 2009, effective Jan. 1, 2010) (China). But the qualification is important: where the patentee shows that the narrowing amendment or statement was specifically denied or not accepted in the grant or confirmation proceeding, surrender may not apply. Zuigao Renmin Fayuan Guanyu Shenli Qinfan Zhuanliquan Jiufen Anjian Yingyong Falü Ruogan Wenti de Jieshi (Er) [Interpretation (II) of the Supreme People’s Court on Several Issues Concerning the Application of Law in the Trial of Patent Infringement Dispute Cases] art. 13 (promulgated Jan. 25, 2016, amended Dec. 23, 2020) (China). China’s donation principle belongs in the same family of claim-scope-limiting doctrines, but it should remain analytically separate: donation concerns technical solutions disclosed in the specification or drawings but not claimed, whereas prosecution-history surrender concerns subject matter given up through amendment or argument. Interpretation of the Supreme People’s Court on Several Issues Concerning the Application of Law in the Trial of Patent Infringement Dispute Cases arts. 5–6.


The practical lesson for patent attorneys is that prosecution history should be drafted as future litigation evidence. Across jurisdictions, amendments should be tied to the precise rejection being addressed; responses should avoid unnecessary invention-level admissions; and commercially important alternatives should be preserved in claims where possible, not merely described in the specification. The legal consequences differ—presumptive surrender in the United States, no true file-wrapper estoppel at the EPO, conscious exclusion in Korea, special circumstances in Japan, and surrendered technical solutions in China—but the strategic discipline is the same: say exactly what is needed to secure allowance or preserve validity, and no more.

 

Comments


About the Author

Brandon R. Theiss

  • LinkedIn
Resize image project - July 22, 2026 at

Brandon R. Theiss is a technology-focused patent attorney with AddyHart’s Divergent IP practice. He advises clients on U.S. patent prosecution, post-grant proceedings, patent eligibility, and patent strategy for technologies including software, cloud computing, data analytics, medical devices, automation systems, and automotive systems. He is an adjunct professor at Villanova School of Law and co-author of FDA and Intellectual Property Strategies for Medical Device Technologies.

Subscribe to Divergent Patent Law Blog
bottom of page